The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often in Biotech.
Cormorant Capital facilitates the growth of real estate owner clients by sourcing equity solutions, in addition to co-investing in select transactions.
Venture capitalcormorant-capital.comRounds from 2023-11-02 to 2026-07-07
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
FORE Biotherapeutics A cancer therapeutics company developing targeted treatments for hard-to-treat tumours | Series D+ Verified against 1 of 6 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $67.4M | 2026-07-07 | [ PART ] |
Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $108M |
| 2026-04-15 |
| [ PART ] |
Terremoto Cutting-edge small-molecule therapies for cancer and other diseases targeted primarily at healthcare providers and researchers. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $175M | 2023-11-02 | [ PART ] |